Abstract

A NICE refusal to approve abatacept [Orencia] for general use in rheumatoid arthritis within the NHS has been upheld in the High Court in London

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call